Neil Gregory Almstead, CHIEF TECHNICAL Operations OFFICER at PTC THERAPEUTICS, INC. (PTCT), sold 4,524 shares at $50.12 ($227K) on 2025-02-20, disclosed to the SEC on 2025-02-21.
Scheduled sale ($227k) by CHIEF TECHNICAL Operations OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.10 | 34 | $2K | 0.8% |
| 2 | $50.10 | 1,300 | $65K | 28.7% |
| 3 | $50.12 | 34 | $2K | 0.8% |
| 4 | $50.12 | 1,578 | $79K | 34.9% |
| 5 | $50.12 | 1,578 | $79K | 34.9% |
| Total | $50.11 avg | 4,524 |
| $227K |
| 100% |
| Filing → |
| PTCT | SELL | 2026-06-30 | $693K | — | Filing → |
| PTCT | SELL | 2026-06-26 | $2.3M | — | Filing → |
| PTCT | SELL | 2026-06-24 | $1.9M | — | Filing → |